All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F24%3A00079884" target="_blank" >RIV/65269705:_____/24:00079884 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/24:00136841

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S0953620524001766?pes=vor" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0953620524001766?pes=vor</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.ejim.2024.04.016" target="_blank" >10.1016/j.ejim.2024.04.016</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial

  • Original language description

    Aims: Screening logs have the potential to appraise the actual prevalence and distribution of predefined patient subsets, avoiding selection biases, which are inevitably and potentially present in randomised trials and real-world registries, respectively. We aimed to assess the prevalence of high bleeding risk (HBR) characteristics in the real world and the external validity of the MASTER DAPT trial. Methods and results: All consecutive patients who underwent percutaneous coronary intervention (PCI) for at least two consecutive weeks across 65 sites participating in the trial were entered into a screening log. Of 2,847 consecutive patients, 1,098 (38.6 %) were HBR and 109 (9.9 %) consented for trial participation. PRECISE-DAPT score GREATER-THAN OR EQUAL TO 25 was the most frequent HBR feature, followed by advanced age, use of oral anticoagulation (OAC) and anaemia. Compared with consecutive HBR patients, consenting patients were older (GREATER-THAN OR EQUAL TO 75 years: 69 % versus 62 %, absolute standardized difference [SD] 0.16), more frequently male (78 % versus 71 %, absolute SD 0.18), had higher use of OAC (38 % versus 20 %, absolute SD 0.39), treatment with steroids or nonsteroidal anti-inflammatory drugs (10 % versus 5 %, SD 0.16), and prior cerebrovascular events (10 % versus 6 %, absolute SD 0.18) but lower PRECISE DAPT score GREATER-THAN OR EQUAL TO 25 (54 % versus 66 %, absolute SD 0.24). Conclusions: The HBR criteria distribution differed between consecutive versus selectively included HBR patients, suggesting the existence of selection biases in the trial population.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30218 - General and internal medicine

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    European Journal of Internal Medicine

  • ISSN

    0953-6205

  • e-ISSN

    1879-0828

  • Volume of the periodical

    126

  • Issue of the periodical within the volume

    AUG 2024

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    6

  • Pages from-to

    89-94

  • UT code for WoS article

    001287622700001

  • EID of the result in the Scopus database

    2-s2.0-85192096994